CD34 and acute myeloid leukemia: The mRNA analysis of five CD34+ cells of healthy donors and 64 AML patients revealed that PAR1 expression was markedly lower in AML blasts than in CD34+ progenitor cells (Fig. 3A), whereas the expression of the other three family members did not differ (Fig. 3B-D).